Literature DB >> 9851395

Myasthenic crisis after botulinum toxin.

G Borodic.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9851395     DOI: 10.1016/S0140-6736(05)79896-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Neuromuscular junction border conflict.

Authors:  Gilles Naeije; Benjamin Legros; Diederik Zegers de Beyl
Journal:  J Neurol       Date:  2010-03-16       Impact factor: 4.849

Review 2.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Ocular myasthenia gravis in a person with tetraplegia presenting challenges in diagnosis and management.

Authors:  Sumitha Gounden; Bonne Lee; Ross Mellick; Susan B Rutkowski; James W Middleton
Journal:  Spinal Cord Ser Cases       Date:  2016-04-07

4.  Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations.

Authors:  Paul S Yamauchi
Journal:  Patient Prefer Adherence       Date:  2010-09-07       Impact factor: 2.711

5.  Cosmetic Injection of Botulinum Toxin Unmasking Subclinical Myasthenia Gravis: A Case Report and Literature Review.

Authors:  Grégory Timmermans; Frédérique Depierreux; François Wang; Isabelle Hansen; Pierre Maquet
Journal:  Case Rep Neurol       Date:  2019-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.